Bioclinic DGL 400mg 180 Chew
Bioclinic DGL, Deglycyrrhizinated licorice, or DGL, has been used clinically for decades, primarily for the treatment of peptic ulcers. Licorice has been shown to inhibit several inflammatory enzymes, including both cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), decreasing the production o...Read More
Clinically, DGL has been shown to have comparable efficacy to cimetidine for both the healing and prevention of ulcer recurrences. Additionally, extracts of licorice have been shown to inhibit the adhesion of H. pylori to gastric mucosa, as well as the growth of antibiotic-resistant strains, suggesting multiple mechanisms of action for its anti-ulcer benefit. The use of chewable tablets appears necessary for DGL’s efficacy, as it allows for distribution and absorption by the gastric mucosa.
• Provides 400mg DGL per tablet, the clinically effective dosage
• Deglycyrrhizination prevents adverse effects associated with licorice consumption
• Delicious chewable tablets for better compliance
Deglycyrrhizinated licorice 10:1 extract (glycyrrhiza glabra) (root) 400mg.
Xylitol, microcrystalline cellulose, aniseed, stearic acid, vegetable grade magnesium stearate (lubricant), silica and stevia rebaudiana leaf.